Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished…
<!-- Name:DistributionId Value:8789833 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Commercialize
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal…
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients.…
CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer…
Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) -- CannaNova Cannabinoid Film CannaNova LLC today announced its formation to pursue the consumer cannabinoid space, employing DepoFilm™…
Intercept Announces Closing of Transaction with Advanz Pharma to Transfer Rights to…
MORRISTOWN, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel…
Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel…
MONTREAL, May 24, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into…
BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop…
- BridgeBio is eligible to receive up to $905 million, including an upfront payment of $90 million, and up to $815 million in additional milestone payments and royalties -SHP2 inhibitor…
Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to…
Taiho obtains exclusive global rights to CLN-081/TAS6417 outside the U.S.; in the U.S., Taiho and Cullinan Oncology to jointly develop and co-commercialize CLN-081/TAS6417 Cullinan…
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement…
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to $90.5 millionMyovant also eligible to receive…
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of…
• Ocugen responsible for commercialization of COVAXIN™ in Mexico • COVAXIN™, already authorized for emergency use in adults by health regulators in Mexico, has been submitted for…
United Partners to Commercialize SAF Production
United Airlines' corporate venture capital fund and Oxy Low Carbon Ventures have partnered with Houston-based biotech firm Cemvita Factory to commercialize the production of sustainable…